September 30, 2025
Scott Bessent May End Taxpayer Funding for Transgender Surgeries
IRS Chief Scott Bessent Could Eliminate $1.2 Billion in Taxpayer-Funded Transgender Procedures Amid Rising National Debate Scott Bessent, the newly appointed acting IRS Commissioner, is at the center of one of the most controversial debates in Washington right now. Just weeks into his appointment on August 8, 2025, he has been given the authority to review which medical procedures qualify under tax-advantaged medical expense accounts, and the implications of his decision could be sweeping. The possibility that he might strike transgender surgeries and hormone treatments from the list of qualified expenses has quickly turned into a national flashpoint, with lawmakers,












